Axtria Unveils Analysis of Critical Trends in Pharma Sales and Marketing
Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, today released an analysis
Pioneering Medical Innovations
Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, today released an analysis
Phase 3 SOL-1 study will evaluate the efficacy and safety of AXPAXLI in wet AMD BEDFORD, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE)
Microsoft Teams is a staple when it comes to collaboration platforms. It enables efficient remote work, while robust security features
Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, announced it is again
Chuck Alpuche Appointed as COO, Peter Griffin as SVP of Operations, Scott Elliott as CLO, Daniel Davis as CSO Seasoned
In the wake of the pandemic, Microsoft Teams has emerged as one of the fastest-growing enterprise applications, facilitating seamless collaboration
SPA amendment expands eligibility criteria for SOL clinical trial Broadening of eligibility criteria anticipated to accelerate overall trial enrollment BEDFORD,
Data calls attention to stroke survivor independence, readmissions, quality of life and adherence to discharge plans December 06, 2023 08:00
First patients treated with investigational Neurovascular Stent System by Dr. Nobuyuki Sakai at Kobe City Medical Center General Hospital, Japan
SANTA CRUZ, Calif. & CAMPBELL, Calif.–(BUSINESS WIRE)–Neurolutions, Inc., the leader in the use of non-invasive brain computer interface (BCI) technology